Ruby Cai
Impact in
- Virology top 5%
- HIV Research and Treatment
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- HIV/AIDS drug development and treatment 6
-
- Virology and Viral Diseases 2
- Hepatitis B Virus Studies 2
- Respiratory viral infections research 2
- Co-authors
- Janet L. Douglas (2 shared papers)Kuei‐Ying Lin (2 shared papers)Tomáš Cihlář (2 shared papers)Edmund Ho (2 shared papers)S. Swaminathan (2 shared papers)Choung U. Kim (5 shared papers)Haolun Jin (4 shared papers)Manuel Tsiang (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Medicinal Chemistry (1 paper)Journal of Virology (1 paper)
- Partner nations
- United StatesBelgium
In The Last Decade
Ruby Cai
9 papers receiving 369 citations
Peers
Comparison fields: 5 of 38
- Virology 86
- Hepatology 77
- Infectious Diseases 179
- Epidemiology 201
- Organic Chemistry 64
Countries citing papers authored by Ruby Cai
This map shows the geographic impact of Ruby Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Cai more than expected).
Fields of papers citing papers by Ruby Cai
This network shows the impact of papers produced by Ruby Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Cai. The network helps show where Ruby Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 105 | |
| 2 | 2005 | 84 | |
| 3 | 2011 | 35 | |
| 4 | 2006 | 34 | |
| 5 | 2012 | 33 | |
| 6 | 2006 | 30 | |
| 7 | 2014 | 26 | |
| 8 | 2021 | 24 | |
| 9 | 2008 | 19 |
About Ruby Cai
Ruby Cai is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Molecular Biology, having authored 9 papers that have together received 390 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (3 papers), Hepatitis C virus research (3 papers), Virology and Viral Diseases (2 papers), Biochemical and Molecular Research (2 papers), Hepatitis B Virus Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Virology (86 citations), Hepatology (77 citations), Infectious Diseases (179 citations), Epidemiology (201 citations) and Organic Chemistry (64 citations). Ruby Cai has collaborated with scholars based in United States and Belgium. Frequent co-authors include Janet L. Douglas, Kuei‐Ying Lin, Tomáš Cihlář, Edmund Ho, S. Swaminathan, Choung U. Kim, Haolun Jin, Manuel Tsiang, Salman Jabri and Xiaowu Chen. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.